Trials / Sponsors / Herbert Hurwitz, MD
Herbert Hurwitz, MD
Academic / Other · 7 registered clinical trials.
| Status | Trial | Phase | Started |
|---|---|---|---|
| Completed | Dose Escalation Study of Pazopanib Plus TH-302 Solid Tumors | Phase 1 | 2011-12-01 |
| Completed | XAD - Xelox (Capecitabine + Oxaliplatin) + Bevacizumab + Dasatinib Solid Tumor, Metastatic Colorectal Cancer | Phase 1 | 2009-05-01 |
| Completed | Safety/Biomarker Study of CNTO 95 and Avastin in Solid Tumors Solid Tumors | Phase 1 | 2009-03-01 |
| Completed | BEP Study Phase I (Bevacizumab, Everolimus, Panitumumab) Solid Tumors | Phase 1 | 2007-11-01 |
| Completed | Bevacizumab, Everolimus, and Erlotinib in Treating Patients With Advanced Solid Tumors Unspecified Adult Solid Tumor, Protocol Specific | Phase 1 | 2005-03-01 |
| Completed | Bevacizumab in Treating Patients With Advanced Solid Tumors Unspecified Adult Solid Tumor, Protocol Specific | Phase 1 | 2004-01-01 |
| Completed | Capecitabine, Oxaliplatin, and Bevacizumab in Treating Patients With Metastatic or Recurrent Colorectal Cancer Colorectal Cancer | Phase 2 | 2003-09-01 |